Infectious Disease Control
Bill and Melinda Gates Release 2021 Annual Letter: "The Year Global Health Went Local"
SEATTLE, Jan. 27, 2021 /PRNewswire/ -- Today, Bill and Melinda Gates share their 2021 Annual Letter, "The Year Global Health Went Local." In this year's letter, Bill and Melinda reflect on the worldwide impact of COVID-19 and the global collaboration and scientific innovation fueling one of the la...
2021-01-27 16:00
2400
CGTN: Hand in Hand: China calls for multilateralism to tackle global crises
BEIJING, Jan. 26, 2021 /PRNewswire/ -- Against the backdrop of a pandemic that has taken tolls on global public health and put the world economy in deep recession, the world in 2020 left many living with fear and uncertainty with the situation further worsening due to other emerging challenges. ...
2021-01-26 03:18
2898
BioVaxys Announces Initiation Of Cancer Vaccine EU Clinical Program, Completion Of BVX-0320 Preclinical Program
VANCOUVER, BC, Jan. 25, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") is pleased to provide a corporate update on recent advancements of its vaccine platforms, and viral diagnostic and corporate objectives for 2021. BioVaxys is ple...
2021-01-25 21:00
3774
Shanghai Electric Strengthens Environmental, Social, and Corporate Governance for Dubai MBR Solar Park Project
SHANGHAI, Jan. 21, 2021 /PRNewswire/ -- Shanghai Electric Group ("Shanghai Electric" or "the Company") has strengthened its environmental, social, and corporate governance for the Phase 5 project forDubai's 900MW Mohammed bin Rashid Al Maktoum Solar Park (MBR Solar Park), winning praise from Shua...
2021-01-21 16:13
7736
LumiraDx Receives SARS-CoV-2 Antigen Test Authorization in Japan and Brazil; Italy Recommends Expansion of Microfluidic Antigen Testing
LONDON, Jan. 21, 2021 /PRNewswire/ -- LumiraDx, the next-generation point-of-care diagnostic testing company, announced today multinational approvals of its SARS-CoV-2 Antigen Test. With approvals inJapan and Brazil, the fast, accurate LumiraDx SARS-CoV-2 Antigen Test is now available to patie...
2021-01-21 16:00
2275
Seegene to advance business in Latin America in the New Year
SEOUL, South Korea, Jan. 21, 2021 /PRNewswire/ -- South Korea's leading molecular diagnostics firm Seegene Inc. (KQ096530) said Wednesday that it is expanding its business inLatin America in the new year with a strong focus on its multiplex assay product. Seegene said it received an approval f...
2021-01-21 07:56
2362
ERBA Mannheim Launches 2nd Generation SARS-CoV-2 RT-PCR Assay with room temperature storage
LONDON, Jan. 21, 2021 /PRNewswire/ -- In response to the ongoing COVID-19 pandemic, Erba today launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for detection of SARS-CoV-2. To overcome challenges in older COVID-19 molecular tests, Erba's Cambridge (UK)-based development team has carefully engineered a ...
2021-01-21 06:00
2590
InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization
BOULDER, Colorado, Jan. 19, 2021 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Measles and Rubella (MR) antigen qu...
2021-01-19 16:00
1438
Air France Awarded 4-Star "COVID-19 Airline Safety Rating" By Skytrax
PARIS, Jan. 15, 2021 /PRNewswire/ -- Air France has been certified with the COVID-19 Airline Safety Rating following the global audit conducted by the international air transport rating agency Skytrax. This audit, carried out in December 2020 on several Air France medium and long-haul flights, eva...
2021-01-15 12:24
3112
Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization
- Ortho's VITROS® SARS-CoV-2 Antigen Test is the first high-volume COVID-19 antigen test to receive Food and Drug Administration (FDA) Emergency Use Authorization (EUA). - With utility for mass-scale testing and same-day results for labs, Ortho's latest COVID-19 solution can run up to 130 tests ...
2021-01-13 03:13
1640
Guide Sensmart Launches New Guide QT Series IR Fever Warning System for Temperature Measurement featuring 5-minute Easy Installation
WUHAN, China, Jan. 13, 2021 /PRNewswire/ -- On December 28, 2020, China's leading company in epidemic prevention and temperature measurement, launched a new fever screening product: the Guide QT Series IR Fever Warning System with infrared thermal imaging and an automatic temperature measuremen...
2021-01-13 01:47
7098
PT Mowilex to Screen Its Workers with COVID-19 Tests from Abbott
JAKARTA, Indonesia, Jan. 12, 2021 /PRNewswire/ -- Indonesian paint manufacturer PT Mowilex is safeguarding workers' health by purchasing COVID-19 diagnostic tests from U.S. health care company Abbott. PT Mowilex will roll out an aggressive testing program to enhance distancing and hygiene protoco...
2021-01-12 14:43
6037
Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients
SUZHOU, China, Jan. 10, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients. The investigator initiated trial conducted by Dr.Andy Goren and Dr. Flávio Adsuara C...
2021-01-10 16:55
3818
Medical Waste Management Inherits a Multi-billion Dollar Opportunity from the Ongoing Pandemic
Asia-Pacific presents immense growth opportunities for medical waste management market participants as regulations mature and are thoroughly enforced, says Frost & Sullivan SANTA CLARA, Calif., Jan. 7, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis,Growth Opportunities in the Medical Wa...
2021-01-07 21:10
2389
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18
- DNA immunotherapy candidate VGX-3100 demonstrated clinically significant reduction of HPV-16/18-associated precancerous vulvar lesions in 63% of treated participants six months after treatment - Phase 2 results indicate that VGX-3100 can be a safe, tolerable and efficacious adjunct to current ...
2021-01-06 21:00
4535
INOVIO and Advaccine Announce Exclusive Partnership To Commercialize COVID-19 DNA Vaccine Candidate, INO-4800, in Greater China
PLYMOUTH MEETING, Pa. and SUZHOU, China, Jan. 4, 2021 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou Co., Ltd. ("A...
2021-01-04 21:00
5244
RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib
Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material safety differences between opaganib and control arms Consistent trends demonstrate greater improvement in reducing oxygen requirement by end of ...
2020-12-31 22:38
8792
INEX Innovate's CORO(TM) Real-Time RT-PCR SARS-CoV-2 Kit for the detection of COVID-19 obtains Singapore's Health Sciences Authority Provisional Authorisation
* The COVID-19 pandemic has seen in excess of 81 million confirmed cases globally and more than 1.7 million deaths and rising daily (1) * CORO™ Real-Time RT-PCR SARS-CoV-2 for the diagnosis of COVID-19, was developed based on three genes recommended by the World Health Organisation (WHO) * ...
2020-12-29 17:24
2661
Universiti Teknologi Malaysia Community responded to COVID-19 threats through R&D
JOHOR BAHRU, Malaysia, Dec. 29, 2020 /PRNewswire/ -- Researchers from Universiti Teknologi Malaysia (UTM) have swung into action to respond to the threat posed by COVID-19 pandemic. Frugal innovations and inventions were developed to improve efficiency and quality in creating relevant and adaptab...
2020-12-29 10:00
3134
Week's Top Stories
Most Reposted
Nine Years of Impact: JULO Disburses USD 1.7 Billion in Digital Financing Across Indonesia
[Picked up by 297 media titles]
2025-12-23 14:23
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 275 media titles]
2025-12-26 12:55The Grand Opening of Dreame Hong Kong Flagship Store Showcases Full Product Lineup
[Picked up by 270 media titles]
2025-12-21 12:42
Fijian and Chinese Scholars Gather to Discuss Bilateral Friendship and the Outlook for APEC 2026
[Picked up by 263 media titles]
2025-12-22 15:56
"Nihao China" App Launches as an All-in-One Solution for International Visitors
[Picked up by 253 media titles]
2025-12-24 17:54